Market News
Stay updated with the latest market trends, earnings, and economic indicators.
10 Nifty 500 stocks plunge over 50% from 52-week highs. Do you own any?
Nifty 500 stocks experienced sharp declines, far exceeding index movements. Several companies saw their values drop by over fifty percent from recent highs. Reliance Power and Cohance Lifesciences are among the biggest losers in this market correction.
Cohance Lifesciences Ltd leads gainers in 'A' group
Piramal Pharma Ltd, Jain Irrigation Systems Ltd, Aarti Pharmalabs Ltd and BASF India Ltd are among the other gainers in the BSE's 'A' group today, 23 June 2026.
Volumes soar at Cohance Lifesciences Ltd counter
Cohance Lifesciences Ltd recorded volume of 9.61 lakh shares by 10:46 IST on BSE, a 12.91 times surge over two-week average daily volume of 74436 shares
Cohance Lifesciences CFO Himanshu Agarwal resigns to pursue opportunity outside company
Cohance Lifesciences announced that Himanshu Agarwal, whole-time director (WTD) and chief financial officer (CFO) has tendered his resignation to pursue a professional opportunity outside the organisation.
NIIT Learning Systems Ltd leads losers in 'A' group
Sky Gold & Diamonds Ltd, Torrent Power Ltd, Cohance Lifesciences Ltd and Kirloskar Brothers Ltd are among the other losers in the BSE's 'A' group today, 13 May 2026.
Cohance Lifesciences shares slip 7% after Jefferies cuts target price, downgrades on weak Q4
Cohance Lifesciences shares dropped significantly after reporting an 84% year-on-year decline in March-quarter net profit. Jefferies downgraded the stock to "Underperform" citing management instability and weak visibility, while Goldman Sachs maintained its "Buy" rating, seeing long-term opportunities despite a challenging near-term outlook.
Cohance Lifesciences Q4 net profit tanks 84%; sees recovery from FY27 second half
EBITDA fell 60% year-on-year to ₹98.7 crore from ₹229.2 crore a year earlier. The EBITDA margin shrank to 15.9% from 27.3% YoY. Shares of Cohance Lifesciences Ltd ended at ₹485.75, up by ₹7.10, or 1.48%, on the BSE.
Q4 Results LIVE Updates: Dr. Reddy's, Dixon report results today; Indian Hotels, Anant Raj react
Q4 Results LIVE Updates: Its an earnings-heavy day on the Dalal Street today. Nifty 50 stock Dr Reddy's Laboratories is scheduled to report its numbers today. Dixon Tech, Berger Paints, Nazara Tech, INOX India, Cohance Lifesciences, Gopal Snacks, Kalpataru, KPR Mill, Max Financial Services, MobiKwik, MTAR Tech, Novartis, Pfizer, Religare, Keystone Developers, Sagility, Tata Power, Torrent Power, Texmaco Rail, V-Guard Industries, are among the other important results to track today. Watch this space for all the LIVE earnings updates.
Gainers & Losers: GRSE, Vedanta among 8 big movers on Wednesday
Indian markets closed higher led by auto, FMCG, and IT stocks. Strong Q4 earnings drove gains in GRSE, CEAT, and Vedanta, while REC, Cohance Lifesciences, and India Cements declined.
Third-worst performing smallcap stock of 2026 gets a big name as CEO; Shares jumps 20%
Cohance's current executive Chairman Vivek Sharma will be stepping down for personal reasons, but will continue to remain with the company for the next nine months as an advisor and help in a smooth transition.
Stocks to Watch Today: Texmaco Rail, RVNL, PNC Infratech, Dr Reddys Labs, MTAR Tech, Cohance Life, Gopal Snacks, Kalpataru Projects in focus on 13 May
Stocks to Watch, 13 May: Stocks like Dr Reddys Laboratories, Tata Power Company, Torrent Power, Nazara Technologies, Sagility, Kalpataru, Neuland Laboratories, Dixon Technologies, Gopal Snacks, Texmaco Rail and Engineering, Cohance Lifesciences, Rail Vikas Nigam, and PNC Infratech will be in focus on May 13.
Cohance shares decline 2% as company CFO resigns
Agarwal was appointed Chief Financial Officer in January 2024. The company has not announced a successor.